摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氨基-3,5-二碘苯甲酸乙酯 | 5400-81-7

中文名称
4-氨基-3,5-二碘苯甲酸乙酯
中文别名
——
英文名称
ethyl 4-amino-3,5-diiodobenzoate
英文别名
ethyl 4-amino-3.5-diiodobenzoate;4-amino-3,5-diiodo-benzoic acid ethyl ester;4-Amino-3,5-dijod-benzoesaeure-aethylester;4-amino-3,5-diiodobenzoic acid ethyl ester
4-氨基-3,5-二碘苯甲酸乙酯化学式
CAS
5400-81-7
化学式
C9H9I2NO2
mdl
MFCD00017092
分子量
416.985
InChiKey
IFLWBYIITJOICR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    52.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2922499990

SDS

SDS:7938cfc7d6563747e09f39ff8e06ab74
查看
Name: Ethyl 4-amino-3 5-diiodobenzoate tech Material Safety Data Sheet
Synonym:
CAS: 5400-81-7
Section 1 - Chemical Product MSDS Name:Ethyl 4-amino-3 5-diiodobenzoate tech Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
5400-81-7 Ethyl 4-Amino-3,5-diiodobenzoate unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Do not store in direct sunlight. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5400-81-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 148 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H9I2NO2
Molecular Weight: 417

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Bases, strong oxidizing agents, acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen iodide, iodine.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5400-81-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl 4-Amino-3,5-diiodobenzoate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 5400-81-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5400-81-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5400-81-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氨基-3,5-二碘苯甲酸乙酯二异丁基氢化铝 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 1.0h, 以70%的产率得到(4-amino-3,5-diiodophenyl)methanol
    参考文献:
    名称:
    Production of three radical cations from a single photon using a photo acid generator
    摘要:
    Efficient generation of the organic radicals is a fundamental technology for preparing the spintronic materials. In this Letter, we present the chemical reaction of the three radical generation from a single photon. A photo acid generator which can release the multiple acid molecules via the automatic amplification mechanism was synthesized. The synthesized acid generator immediately released methanesulfonic acid by UV irradiation. Due to the amplification system, a maximum of three acid molecules can be produced from the single acid generator. In addition, the release of acid is induced by UV irradiation and automatically proceeds until the release of three acid molecules is finished. Finally, by employing the acid-catalyzed radical generation of tetrathiafulvalene, we also demonstrate the efficient radical generation triggered by UV irradiation in the polymer film. (c) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2014.01.092
  • 作为产物:
    描述:
    苯佐卡因一氯化碘 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以87%的产率得到4-氨基-3,5-二碘苯甲酸乙酯
    参考文献:
    名称:
    碘氨基戊定和相关化合物:对组胺H2受体具有高亲和力和选择性的新型配体。
    摘要:
    描述了一种新型的具有N-氰基-N'-[ω-[3-(1-(哌啶基甲基)苯氧基]烷基]胍部分结构的组胺H2拮抗剂的合成和生物学评估,作为广泛研究计划的一部分,以寻找用于开发具有高H2亲和力和比活性的新型放射性配体的模型化合物。高的受体亲和力是通过一个附加的(取代的)芳环实现的,该芳环通过碳链间隔基和一个胺,羧酰胺,酯或磺酰胺键(“极性基团”)与第三胍N连接。在针对豚鼠心房和回肠以及大鼠主动脉和尾动脉的H2拮抗活性和其他药理作用(例如H1抗组胺药,抗毒蕈碱,抗肾上腺素(α1,β1),5-HT2阻断活性)的功能研究中,该化合物被证明是高效和选择性的组胺H2受体拮抗剂。H2拮抗活性主要取决于N'-烷基链(链A)和N“-间隔基(链B)的长度。具有C3链A和C2链B的化合物最有效。一类物质,即羧酰胺系列,在芳香环上具有广泛的取代基,其中包括碘,氨基和叠氮基,这些化合物在分离的豚鼠右心房中的效能比西咪替丁
    DOI:
    10.1021/jm00090a013
点击查看最新优质反应信息

文献信息

  • Synthesis of Indoles: Efficient Functionalisation of the 7-Position
    作者:Emmanuel Demont、Nicolas Charrier、Rachel Dunsdon、Graham Maile、Alan Naylor、Alistair O’Brien、Sally Redshaw、Pam Theobald、David Vesey、Daryl Walter
    DOI:10.1055/s-2006-950223
    日期:2006.10
    Traditional strategies in indole chemistry do not allow high-yielding access to some substitution patterns such as 3,5,7-trisubstituted indoles. We report in this article the efficient synthesis of this type of indole. The Heck cyclisation strategy we used allows the synthesis of 7-iodo-, 7-alkoxy-, 7-amino-, and 7-nitroindoles bearing other functionalities at the 3- and 5-positions. We believe that
    吲哚化学中的传统策略不允许高产地获得某些取代模式,例如 3,5,7-三取代吲哚。我们在本文中报告了这种类型吲哚的有效合成。我们使用的 Heck 环化策略允许合成在 3 位和 5 位具有其他官能团的 7-碘-、7-烷氧基-、7-氨基-和 7-硝基吲哚。我们认为,所使用的温和条件应允许制备在这两个位置具有广泛取代基的吲哚,如合成 5-溴-7-碘吲哚所示。然而,这种策略在非常缺电子的吲哚(例如 7-硝基吲哚)的情况下存在一些局限性,其中 7-硝基二氢吲哚中间体的芳构化不完全。在这种情况下,拉洛克'
  • Preparation of Polyfunctional Heterocycles Using Highly Functionalized Aminated Arylmagnesium Reagents as Versatile Scaffolds
    作者:David M. Lindsay、Wolfgang Dohle、Anne Eeg Jensen、Felix Kopp、Paul Knochel
    DOI:10.1021/ol025597x
    日期:2002.5.1
    [reaction: see text] Functionalized Grignard reagents, derived from readily available o-iodoaniline derivatives and obtained via a straightforward iodine-magnesium exchange, can be used to prepare a wide range of polyfunctional indoles, quinolines, and quinazolinones.
    [反应:见正文]衍生自易得的邻碘苯胺衍生物并通过直接的碘镁交换获得的功能化格氏试剂可用于制备多种多官能吲哚,喹啉和喹唑啉酮。
  • [EN] HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] DERIVES D'HYDROXYETHYLAMINE UTILISES POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
    申请人:GLAXO GROUP LTD
    公开号:WO2004050619A1
    公开(公告)日:2004-06-17
    The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated - amyloid levels or -amyloid deposits, particularly Alzheimer's disease.
    本发明涉及具有Asp2(-分泌酶,BACE1或Memapsin)抑制活性的新型羟乙基胺化合物的化学式(I):(I),其制备方法,含有它们的组合物以及它们在治疗由高β-淀粉样蛋白水平或β-淀粉样蛋白沉积所特征的疾病中的应用,特别是阿尔茨海默病。
  • [EN] TRICYCLIC INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] DERIVES D'INDOLE TRICYCLIQUES ET LEUR UTILISATION DANS LE CADRE DU TRAITEMENT DE LA MALADIE D'ALZHEIMER
    申请人:GLAXO GROUP LTD
    公开号:WO2004094430A1
    公开(公告)日:2004-11-04
    The present invention relates to novel hydroxyethylamine compounds having Asp2 (β-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β- amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.
    本发明涉及具有Asp2(β-分泌酶、BACE1或Memapsin)抑制活性的新型羟乙基胺化合物,其制备方法,含有它们的组合物以及它们在治疗由β-淀粉样蛋白水平或β-淀粉样蛋白沉积物升高而特征化的疾病,特别是阿尔茨海默病中的用途。
  • Synthesis of 3,5,7-Substituted Indoles via Heck Cyclisation
    作者:Emmanuel Demont、Nicolas Charrier、Rachel Dunsdon、Graham Maile、Alan Naylor、Alistair O’Brien、Sally Redshaw、Pam Theobald、David Vesey、Daryl Walter
    DOI:10.1055/s-2005-921917
    日期:——
    Traditional strategies in indole chemistry do not allow high yielding access to some substitution patterns such as 3,5,7-trisubstituted indoles. We report in this article the efficient synthesis of this type of indole. The Heck cyclisation strategy we used allows the synthesis of 7-iodo-, 7-nitro-, 7-amino- or 7-alkoxy indoles bearing other functionalities in the 3- and 5-positions. We believe the
    吲哚化学中的传统策略不允许高产地获得某些取代模式,例如 3,5,7-三取代吲哚。我们在本文中报告了这种类型吲哚的有效合成。我们使用的 Heck 环化策略允许合成在 3-位和 5-位具有其他官能团的 7-碘-、7-硝基-、7-氨基-或 7-烷氧基吲哚。我们相信所使用的温和条件应该允许在这两个位置上制备具有广泛取代基的吲哚。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐